MEASURE: Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Complete Title: MEASURE: Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
Trial Phase: N/A
Investigator: Elizabeth Krakow

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

N/A
Elizabeth Krakow
RG1122288
MEASURE: Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events